KLF5 and cancer: The KLF5 transcription factor, an oncogene implicated in several cancers including CRC, exhibits hotspot E419Q mutations in its DNA binding domain results in over 5000 gained binding sites compared to WT KLF5 including de novo SEs at pro-tumorigenic genes [14].